Dihydroergotoxine mesylate Size:Solid 2 mg ) exhibits an anti-tumor effect

) exhibits an anti-tumor effect on pancreatic cancer xenografts in mice

InChi: InChI=1S/C22H21ClN6O2/c1-2-3-8-18-24-20(23)19(22(30)31)29(18)13-14-9-11-15(12-10-14)16-6-4-5-7-17(16)21-25-27-28-26-21/h4-7

Hopkins CR

PubMed PMID: 27145925

Dihydroergotoxine mesylate Size:Solid 2 mg ) exhibits an anti-tumor effectErgoloid Mesylates, also known as dihydroergotoxine mesylate, is a mixture of three dihydrogenated ergot alkaloids (dihydroergocristine, dihydroergocornine, and alpha and beta dihydroergocryptine). Ergoloid mesylates is used as a treatment for dementia and Alzheimer disease. Ergoloid Mesylates stimulates dopaminergic and serotonergic receptors and blocks alpha adrenoreceptors. Ergoloid Mesylates binds to the GABAA receptor Cl channel, producing a